Induction Therapy With Paclitaxel and Bevacizumab Followed by Switch Maintenance Therapy With Eribulin in Japanese Patients With HER2-negative Metastatic Breast Cancer: A Multicenter, Collaborative, Open-Label, Phase II Clinical Study for the SBCCSG 35 Investigators
BMC Cancer - United Kingdom
doi 10.1186/s12885-018-4556-6
Full Text
Open PDFAbstract
Available in full text
Date
June 20, 2018
Authors
Publisher
Springer Science and Business Media LLC